top of page

About Us

We at FarBeyondz, understand that not everyone is able or willing to consume most of our ingredients in their raw forms, despite their wide range of health benefits, and further most of these spices can be rather unpalatable for the human tongue when consumed raw. Also, they may not be readily available in your country or region. That’s why we have come up with our inaugural product, where we combine these ingredients and packaged it for easy consumption. We uses a combination of east and west knowledge on our product to achieve its best benefits and potency. Rest assured that they have been thoroughly laboratory-tested for their optimum performance, so with each drop you will be consuming the maximum benefits that these spices have to offer!

Our Research Consultant

Dr Khairunisa

Farbeyondz Pte Ltd specializes in producing high-quality health supplements. Our research team consists of experts with extensive knowledge and experience in the health and nutrition industry. With their keen eye for detail, they strive to produce the most reliable and effective range of health supplements available. We take quality assurance very seriously. Our products are tested rigorously for quality control and assurance. We use quality check samples to ensure that only the highest quality ingredients are used in the production of our products. Additionally, we also conduct regular tests to ensure that the products meet the highest standards of safety and efficacy. All of our products are free from contaminants and are manufactured in accordance with Good Manufacturing Practices (GMP) compliant to ensure the highest levels of quality. We are committed to providing our customers with the best quality products available.

Dr Khairunisa NUS Medical

Our leading Research Consultant, Dr(PhD) Khairunnisa' Mohamed Hussain graduated from the National University of Singapore (NUS) in 2015 with a PhD in Medicine (Microbiology). She also completed her MSc in Medicine (Infection and Immunity, Honours) from the University of Sydney, Australia in 2009 and BSc in Life Sciences from NUS in 2007. 

During her postgraduate years, Dr(PhD) Nisa worked on vaccines, infectious entry routes and celullar models for viral infection and pathogenesis of such viruses as enterovirus 71 and chikungunya. Major experiments performed include animal studies, cell culture, virus propagation and purification, growth kinetics studies, drug inhibitory assays, microarray gene expression analysis, siRNA transfection studies, quantitative real-time PCR, microscopy analyses (indirect immunofluorescence and transmission electron) and statistical analyses. 

As a result, she has authored several publications in high-impact journals, including the Journal of Virology, Journal of Biological Chemistry and PLoS Neglected Tropical Diseases. Nisa has also successfully presented her scientific work at local and international research conferences, such as the International Meeting on Emerging Diseases and Surveillance in Vienna (Austria, 2011), Nagasaki-Singapore Symposium on Infectious Disease in Singapore (2010) and International Congress on Infectious Diseases in Miami (USA, 2009).

Biography:

​

PUBLICATIONS

  • Lee, R.C., Hussain, K.M., and Chu, J.J. (2019). Macropinocytosis dependent entry of Chikungunya virus into human muscle cells. PLOS Negl Trop Dis. 13(8):e0007610.

  • Hussain, K.M., Ng, M.M., and Chu, J.J. (2016). Establishment of a novel primary human skeletal myoblast cellular model for Chikungunya virus infection and pathogenesis. Sci Reports. 6:21406.

  • Lee, R.C., Hapuarachchi, H.C., Chen, K.C., Hussain, K.M., Chen, H., Low, S.L., Ng, L.C., Lin, R., Ng, M.M., and Chu, J.J. (2013). Mosquito cellular factors and functions in mediating the infectious entry of chikungunya virus. PLoS Negl Trop Dis. 7(2):e2050.

  • Hussain, K.M., and Chu, J.J. (2011). Insights into the interplay between chikungunya virus and its human host. Future Virol. 6(10):1211-1223.

  • Hussain, K.M., Leong, K.L., Ng, M.M., and Chu, J.J. (2011). The essential role of clathrin-mediated endocytosis in the infectious entry of human enterovirus 71. J Biol Chem. 286(1):309-321.

  • Bek, E.J., Hussain, K.M., Phuektes, P., Kok, C.C., Gao, Q., Cai, F., Gao, Z., and McMinn, P.C. (2011). Formalininactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection. Vaccine. 29(29-30):4829-4838. ACADEMIC HONOURS

  • Contributed to research and writing in the Islamic Reform Initiative (IRI), a mega-project launched by College of Islamic Studies, Hamad Bin Khalifa University to produce a comprehensive source on Islamic reform (Qatar; Jun – Aug 2021).

  • Co-wrote a chapter (Chaper 12 - The Case of IbTECHar: Fostering Entrepreneurship Education in Qatar) in Localizing Entrepreneurship Education: Global Perspectives, Qatari Experiences by M. E. Tok and A. Al-Fadala (Qatar; 2021). ï‚· Facilitated in the AHD (Pledge) for Post-Covid Humanity program, a global youth social event hosted by Hamad Bin Khalifa (Qatar; 2021 Mar 20-21).

  • Participated in the Design Post-Covid Humanity (DPCH) program, an innovative global educational initiative hosted by Hamad Bin Khalifa University (Qatar; Nov 2020 – Jan 2021).

  • Dean’s honours list, College of Islamic Studies, Hamad Bin Khalifa University (HBKU) (Qatar; Jun 2020). ï‚· Shortlisted to present at the Maker Majlis Covid-19 and the Global Moral Panic: Youth Ignition Challenge (Hamad Bin Khalifa University, Qatar; 2020 Apr 21).

  • Facilitated in the Maker Majlis: Islam in a Global World event, an innovative educational space focused on localizing Sustainable Development Goals (SDGs) and making them relevant to Qatar and the Muslim world (Hamad Bin Khalifa University, Qatar; 2019 Sep 22-25).

  • Represented the department and awarded the SPD Scientific Best Poster Presentation Prize for a poster presentation at The Inaugural Microbiology Students’ Symposium (National University of Singapore, Singapore; 2013 Jan 14-15).

bottom of page